Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.
University of Minnesota-spinoff Orasi Medical Inc. raised $1.8 million from the sale of equity, according to a Securities & Exchange Commission filing.
Overall, the software startup hopes to raise $2.6 million by December.
CEO Shawn Lyndon declined to comment, citing SEC rules that prohibit public comments on fundraising activities.
The company, which generates less than $1 million a year in revenue, is developing software designed to help pharmaceuticals makers speed the development of drugs targeting neurological diseases, like Alzheimer’s.